Abstract
Epidermal keratinocytes play a vital role in restoration of the intact skin barrier during wound healing. The negative effect of hyperglycemia may prolong the wound healing process. Epidermal keratinocytes have been demonstrated to modulate and directly initiate nociceptive responses in rat models of fractures and chemotherapy-induced neuropathic pain. However, it is unclear whether epidermal keratinocytes are involved in the development and maintenance of incisional pain in nondiabetic or diabetic animals. In the current study, using behavioral tests and immunohistochemistry, we investigated the differential keratinocytes proliferation and expression of pronociceptive inflammatory mediators in keratinocytes in C57BL/6J mice and diabetic KK mice. Our data showed that plantar incision induced postoperative pain hypersensitivity in both C57BL/6J mice and KK mice, while the duration of postoperative pain hypersensitivity in KK mice was longer than that in C57BL/6J mice. Moreover, plantar incision induced the keratinocytes proliferation and expression of IL-1β and TNF-α in keratinocytes in both C57BL/6J mice and KK mice. Interestingly, compared to C57BL/6J mice, the slower and more persistent proliferation of keratinocytes and expression of IL-1β and TNF-α in keratinocytes were observed in KK mice. Together, our study suggested that plantar incision may induce the differential keratinocytes proliferation and expression of IL-1β and TNF-α in kertinocytes in diabetic and nondiabetic animals, which might be associated with the development and maintenance differences in diabetic and nondiabetic postoperative pain.
Keywords: Keratinocytes, postoperative pain, diabetes, inflammation
Introduction
Clinical pain management after surgery is far from being successful despite dramatically increased attentions. Many patients develop chronic pain after surgery which might be, at least in part, a result of undertreated acute postoperative pain. The pathophysiology of postoperative pain is very different from the inflammatory or neuropathic pain1 and thus it is necessary to gain new insights into the mechanisms of postoperative pain in experimental settings to develop therapeutic options with greater efficacy and less risk of adverse effects. Peripheral sensitization is a contributing factor for central sensitization. Continuous pathogenetic impulses from the periphery might further consolidate and aggravate central sensitization. In recent years, peripheral mechanisms in postoperative pain have been sharing the same degree of attention as central mechanisms. Accumulated evidences suggested that the inflammatory and ischemic-like conditions including increased lactate, NGF, IL-1β, and C5a in the incisional wound contribute to peripheral sensitization and pain behavior after incision.2,3 However, the detailed cellular and molecular mechanisms underlying peripheral sensitization of postoperative pain are not fully understood.
Wound healing occurs as a cellular response to injury and involves activation of keratinocytes, fibroblasts, endothelial cells, macrophages, and platelets.4 Many growth factors and cytokines released by these cell types are needed to coordinate and maintain healing.5–8 Keratinocytes, which comprise most of the epidermis, through terminal differentiation, develop a mechanical barrier against chemical stimulus and microorganism. During wound healing, due to the skin environmental changes, the function of keratinocyte also changes.9 Previous studies showed that keratinocyte, through activation, proliferation, and release of proinflammatory mediators,10–13 plays a critical role in the peripheral sensitization of pain in rat models of fracture and chemotherapy-induced neuropathic pain. Therefore, the keratinocyte is possibly involved in the development and maintenance of incisional pain, as a cellular response during wound healing.
Interestingly, during diabetic wound healing, the keratinocyte shows an absence of migration, hyperproliferation, and incomplete differentiation.4,14,15 The evidence from clinical study indicates that diabetic patients have higher pain scores and need larger doses of morphine for effective postoperative pain treatment compared with nondiabetic patients.16 However, it is unclear whether epidermal keratinocytes are involved in the differential development and maintenance of incisional pain in nondiabetic or diabetic animals. Therefore, in the current study, we aimed to determine the differential keratinocytes activation and proliferation as well as expression of pronociceptive inflammatory mediators in keratinocytes between C57BL/6J mice and KK mice.
Methods
Animals
Adult male C57BL/6J (9–11 weeks, 25–28 g) and KK mice (blood sugar >11.1 mmol/L, 9–11 weeks, 25–28 g) were purchased from Huafukang Company. All the mice were housed on a 12-h light/12-h dark cycle and maintained at 21°C ± 2°C with free access to food and water. High-fat diet is provided to KK mice and regular diet is provided to C57BL/6J mice. All experiments were approved by the Ethical Committee of Beijing Friendship Hospital, Capital Medical University, China and were performed in compliance with the guidelines for animal experimentation of the international association for the study of pain.
Plantar incision
The plantar incision in mice was performed as described previously.17 We use 1.5% to 2% isoflurane to anesthetize the mice. A 5-mm longitudinal incision was made in right heel. The skin and muscle were incised by a No. 11 blade. The muscle origin and insertion were kept intact. In addition, 8–0 nylon was used to suture the skin. The wound was closed and covered with antibiotic ointment to be protected from infection.
Behavior tests
The mice were put on an elevated iron mesh floor to acclimate for 20 to 30 min. Then the paw withdrawal threshold (PWT) and cumulative pain score (CPS) were assessed. PWT was assessed with the up-down method using von Frey filaments (North Coast Medical, USA) from 0.04 to 2.0 g (0.04, 0.07, 0.16, 0.4, 0.60, 1.0, 1.4, 2.0 g).18 We first applied 0.04 g stimulus to an area near the wound for 5 s or stop when the animal withdrew the paw. We decreased the stimulus if the mice had a positive response, such as rapid lifting, shaking, or licking of the incised paw, or we increased the stimulus if the mice have a negative response. CPS was used to assess nonevoked pain behaviors. The mice were observed closely for a 1-min period every 5 min for 1 h. Based on the way that the right hind paw was positioned, a score of 0, 1, or 2 was given. Zero point was recorded when the right hind paw touched the mesh and made the mesh blanch or distort. One point was recorded when the right hind paw touched the mesh and did not make the mesh blanch or distort. Two point was recorded when the right hind paw did not touch the mesh. The sum of the 12 scores (0–24) was recorded as CPS.
Antibodies
The sources of primary antibodies in this experiment were as follows: Cytokeratin (clone AE1/AE3) (ma-1316, 1:100, Thermo Fisher Scientific, Waltham, MA); IL-1β (ab2105, 1:100, Abcam Systems, Cambridge, UK), TNF-α(ab6671, 1:100, Abcam Systems, Cambridge, UK), Proliferating cell nuclear antigen (PCNA) (GB11010, servicebio, 1:200, Wuhan, China). The sources of secondary antibodies were as follows: Cy3 conjugated Goat Anti-rabbit IgG (GB21303, servicebio, 1:300, Wuhan, China), Alexa Fluor® 488-conjugated AffiniPure Goat Anti-mouse IgG (GB25301, servicebio, 1:400, Wuhan, China).
Immunofluorescence
The mice were euthanized by overdose of chloral hydrate.10 Moreover, 4% paraformaldehyde and the saline were used for perfusion. The hindpaw skin of the incision margin was collected in 4% tissue fix solution (Soarbio, P1110) for 24 h. The tissue was removed from the tissue fix solution and was dehydrated in a stepwise gradient of alcohol and anhydrous ethanol. Melted paraffin was used to infiltrate tissue. The skin was embedded in melted paraffin and then kept at −20°C to solidify the paraffin. Following embedding, 4-μm-thick slices were made and baked in an oven at 60°C, and were then stored at room temperature. Paraffin section was blocked with BSA for 30 min after dehydration and antigen repair. The primary antibodies were applied, respectively, overnight at 4°C in phosphate-buffered saline (PBS). The glass slides were then washed in PBS buffer (PH 7.4) three times, 5 min each. The secondary antibodies were incubated for 50 min at room temperature, followed by washing in PBS buffer (PH 7.4) three times, 5 min each. The 4',6-diamidino-2-phenylindole was used to stain nuclear for 10 min at room temperature. The glass slides were covered with anti-fluorescence quenching tablets after washing in PBS buffer (PH 7.4) three times. Images were obtained using confocal microscopy (Nikon Eclipse C1).
Statistical analysis
All data analysis was performed by GraphPad Prism 6. Quantitative analysis for Behavioral data was analyzed by one-way analysis of variance (ANOVA). For comparisons of the expression of cytokeratin at different time points, we used ANOVA followed by Bonferroni multiple comparison tests. The data of PCNA numbers at different time points were also analyzed with ANOVA followed by Bonferroni multiple comparison tests. All data are expressed as mean ± standard error of the mean. P < 0.05 was regarded as significant.
Results
Postoperative pain hypersensitivity was significantly prolonged in KK mice after plantar incision
In C57BL/6J mice, the lowest PWT and highest CPS of the ipsilateral paw to the incision were observed at 6 h after incision and remained for one day (P < 0.01, Figure 1(a) and (b)). Then, the PWT and CPS gradually recovered, but remained different from the preoperative level at three days after incision (P < 0.01, Figure 1(a) and (b)). The PWT and CPS completely recovered to the preoperative level at five and seven days after incision (P > 0.05, Figure 1(a) and (b)). In KK mice, the lowest PWT and highest CPS of the ipsilateral paw to the incision were also observed at 6 h after incision and remained for three days (P < 0.01, Figure 1(a) and (b)). Then, the PWT and CPS gradually recovered but still remained different from the preoperative level at five and seven days after incision (P < 0.05, Figure 1(a) and (b)). Compared to the C57BL/6J mice, the PWT still remained significantly lower and CPS remained higher at three, five, and seven days after incision in KK mice (P < 0.01, Figure 1(a) and (b)).
Figure 1.
The duration of pain hypersensitivity after plantar incision was prolonged in KK mice as compared to C57BL/6J mice. In C57BL/6J mice, the lowest PWT and highest CPS of the ipsilateral paw to the incision were observed at 6 h after incision and remained for one day (P < 0.01). Then, the PWT and CPS gradually recovered to the preoperative level on five and seven days after incision (P > 0.05). In KK mice, the lowest PWT and highest CPS of the ipsilateral paw to the incision were also observed at 6 h after incision and remained for three days (P < 0.01). Then, the PWT and CPS gradually recovered but still remained different from the preoperative level on day 5 and day 7 after incision (P < 0.05). Compared to the C57BL/6J mice, the PWT was significantly lower and the CPS was significantly higher on days 3, 5, and 7 after incision in KK mice (P < 0.01). PWT, paw withdrawal threshold; CPS, cumulative pain score; **P < 0.01, compared with preoperative values; ##P < 0.01, #P < 0.05 compared with the C57BL/6J mice; n = 8.
Plantar incision induced the differential proliferation of keratinocytes in the margin skin of the incision between C57BL/6J and KK mice
The keratinocyte proliferation in the margin skin of the incision was characterized by the epidermal thickness and the numbers of PCNA cells with positive cytokeratin labeling. In C57BL/6J mice, the epidermal thickness increased at one day after incision (P < 0.05, Figure 2(a) and (b)), peaked at three days after incision (P < 0.01, Figure 2(a) and (b)), and then gradually recovered. But even at seven days after incision, the epidermal thickness is still higher than that in normal control group (P < 0.05, Figure 2(a) and (b)). In KK mice, the epidermal thickness began to increase at one day after incision (P < 0.05, Figure 2(a) and (c)), and reached the peak at seven days after incision (P < 0.01, Figure 2(a) and (c)).
Figure 2.
The differential proliferation of keratinocytes in the margin skin of the incision in C57BL/6J and KK mice. Representative confocal images of cytokeratin (a keratinocyte marker, green) and PCNA (red) immunoreactivity in the margin incision skin. Colocalization (merge) is shown in yellow/orange. Scale bars: 50 μm. In C57BL/6J mice, the epidermal thickness increased at one day after incision (P < 0.05), peaked at three days after incision (P < 0.01), and then gradually recovered. In KK mice, the epidermal thickness began to increase at one day after incision (P < 0.05), and reached the peak at seven days after incision (P < 0.01). In C57BL/6J mice, the number of PCNA cells with positive cytokeratin labeling increased at one day after incision(P < 0.05), peaked at three days after incision (P < 0.01), and then gradually returned to the level in control group at seven days after incision (P > 0.05). In KK mice, the number of PCNA cells with positive cytokeratin labeling began to increase at one day after incision (P < 0.05), and reached the highest level at seven days after incision (P < 0.01). PCNA, proliferating cell nuclear antigen. *P < 0.05, **P < 0.01, compared with preoperative values; ##P < 0.01, #P < 0.05 compared with the C57BL/6J mice; n = 4–6.
In C57BL/6J mice, the number of PCNA cells with positive cytokeratin labeling increased at one day after incision (P < 0.05, Figure 2(a) and (c)), peaked at three days after incision (P < 0.01, Figure 2(a) and (c)), and then gradually returned to the level of normal control group at seven days after incision (P > 0.05, Figure 2(a) and (c)). In KK mice, the number of PCNA cells with positive cytokeratin labeling began to increase at one day after incision (P < 0.05, Figure 2(a) and (c)), and reached the highest level at seven days after incision (P < 0.01, Figure 2(a) and (c)). Both the epidermal thickness and the number of PCNA cells in contralateral hindpaw did not change at those time points (data not shown).
The differential expression of IL1β in keratinocytes between C57BL/6J and KK mice
The plantar incision induced the co-expression of cytokeratin and IL1β in margin incision skin in both C57BL/6J mice and KK mice. In C57BL/6J mice, the co-expression of cytokeratin and IL1β gradually increased and reached the peak at three days after incision (P < 0.01, Figure 3(a) and (b)). And then the co-expression of cytokeratin and IL1β gradually decreased but still kept at higher level as compared to the control group at seven days after incision (P < 0.05, Figure 3(a) and (b)).
Figure 3.
The plantar incision induced the IL1β expression in keratinocytes in margin incision skin in both C57BL/6J mice and KK mice. Representative confocal images of cytokeratin (green) and IL1β(red) immunoreactivity in the margin incision skin. Colocalization (merge) is shown in yellow/orange. The left columns of both groups are shown in lower magnification. The right columns of both groups are shown in higher magnification. Scale bars: 50 μm (lower magnification) and 20 μm (higher magnification). In C57BL/6J mice, the co-expression of cytokeratin and IL1β gradually increased and reached the peak at three days after incision (P < 0.01). Then the co-expression of cytokeratin and IL1β gradually decreased but still kept at a higher level in contrast to the control group at seven days after incision (P < 0.05). There was no difference in the co-expression of cytokeratin and IL1β at 6 h, one day, and three days after incision between C57BL/6J mice and KK mice (P > 0.05). However, at five or seven days after incision, the co-expression of cytokeratin and IL1β in KK mice was significantly higher than that in C57BL/6J mice (P < 0.01). *P < 0.05, **P < 0.01, compared with preoperative value; ##P < 0.01, compared with the C57BL/6J mice; n = 4–6.
In KK mice, the level of co-expression of cytokeratin and IL1β was increased from (63.67 ± 14.09 cells/HPF, n = 6) at one day after incision to (156.5 ± 32.27 cells/HPF, n = 4-6) at seven days after incision. There was no difference in the level of co-expression of cytokeratin and IL1β at 6 h, one day, and three days after incision between C57BL/6J mice and KK mice (P > 0.05, Figure 3(a) and (b)). However, at five and seven days after incision, the co-expression of keratinocyte and IL1β in KK mice was significantly higher than that in C57BL/6J mice (P < 0.01, Figure 3(a) and (b)).
The differential expression of TNFα in keratinocytes between C57BL/6J mice and KK mice
Plantar incision induced the co-expression of cytokeratin and TNFα in margin incision skin in both C57BL/6J and KK mice. In C57BL/6J mice, the co-expression of cytokeratin and TNFα began to increase at one day after incision (P < 0.05, Figure 4(a) and (b)) and reached the peak at three days after incision (P < 0.01, Figure 4(a) and (b)). Then, the level of co-expression of cytokeratin and TNFα returned to the baseline value at five and seven days after incision (P > 0.05, Figure 4(a) and (b)).
Figure 4.
Plantar incision induced the TNFα expression in keratinocytes in margin incision skin in both C57BL/6J and KK mice. Representative confocal images of cytokeratin (green) and TNFα (red) immunoreactivity in the margin incision skin. Colocalization (merge) is shown in yellow/orange. The left columns of both groups are shown in lower magnification. The right columns of both groups are shown in higher magnification. Scale bars: 50 μm (lower magnification) and 20 μm (higher magnification). In C57BL/6J mice, the co-expression of cytokeratin and TNFα began to increase at one day after incision (P < 0.05) and reached the peak at three days after incision (P < 0.01). Then, the level of co-expression of cytokeratin and TNFα at five and seven days after incision returned to the baseline value (P > 0.05). There was no difference in the co-expression of cytokeratin and TNFα at 6 h, one day, and three days after incision between C57BL/6J mice and KK mice (P > 0.05). However, at five or seven days after incision, the co-expression of cytokeratin and TNFα in KK mice was significantly higher than that in C57BL/6J mice (P < 0.01). *P < 0.05, **P < 0.01, compared with preoperative value; n = 4–6.
In KK mice, the level of co-expression of cytokeratin and TNFα was gradually increased from (73.33 ± 8.48 cells/HPF, n = 4-6) at one day after incision to (114.00 ± 28.95 cells/HPF, n = 4-6) at seven days after incision. There was no difference in the level of co-expression of cytokeratin and TNFα at 6 h, one day, and three days after incision between C57BL/6J mice and KK mice (P > 0.05, Figure 4(a) and (b)). However, at five and seven days after incision, the co-expression of cytokeratin and TNFα in KK mice was significantly higher than that in C57BL/6J mice (P < 0.01, Figure 4(a) and (b)).
Discussion
The current study has demonstrated that plantar incision induced the prolonged duration of pain hypersensitivity in diabetic animals. Additionally, the keratinocyte proliferation after plantar incision in diabetic mice is slower and more persistent as compared to that in nondiabetic mice. Furthermore, the expression of IL1β and TNFα in keratinocytes of nondiabetic mice reached the peak at three days after incision and gradually returned to the baseline. In contrast, in diabetic mice, the expression of IL1β and TNFα in keratinocytes persistently increased from one day after incision and reached the peak at seven days after incision.
Keratinocytes are the most common type of cells in the skin and play an important role in wound healing. Wound healing is a complicated process that requires several distinct components, including hemostasis, inflammation, proliferation, and remodeling. During proliferation process, epidermal re-epithelialization and dermal repair are coordinated.19 The involvement of keratinocytes proliferation in nociception has been reported in a rat model of tibial fracture.10 KK mouse we used in this paper is a good obesity-associated diabetes model. The hyperglycemia and glucose intolerance in KK mice are similar to that in type 2 diabetes patients.20,21 In current study, the keratinocyte proliferation peaked at three days after incision in C57BL/6J mice, while it peaked at seven days after incision in KK mice. Usui et al. reported that a proliferative burst of keratinocytes occurs between 24 and 72 h after injury in normal acute wounds,22 which is consistent with our present study in C57BL/6J mice. Additionally, our study also indicated that the incision-induced keratinocytes proliferation develops slowly and lasts longer in diabetic animals. The maximal epidermal thickness and the highest amount of PCNA cells with positive cytokeratin labeling are almost the same inC57BL/6J mice and KK mice. However, it takes more days to reach the peak in KK mice, indicating that keratinocytes proliferation is inhibited in diabetic animals. Some studies demonstrated that keratinocytes contact with the sensory afferent nerves in function.23–25 Keratinocytes contribute to the initial transduction process by regulating the release of many neuroactive substances after tissue injury.26,27 In our current study, the number of keratinocytes and the expression of cytokines in keratinocytes at three days after incision did not match the changes of pain behaviors in C57BL/6J and KK mice. It indicates that the pain behaviors at three days after incision did not uniquely/exclusively result from the increased number of keratinocytes and the increased expression of cytokines in keratinocytes. There might be other molecules which are mainly responsible for the development of pain at three days after incision in nondiabetic mice. We will investigate this interesting phenomenon in the future.
Interleukin-1β (IL-1β) is a cytokine with multifunctional biological activity in the interleukin family. TNF-α is one of the cytokines involved in systemic inflammation. IL-1β and TNF-α can be synthesized by a variety of cells, such as macrophages, monocytes, and keratinocytes.28 Previous studies reported that there were two peaks of the expression IL-1β and TNF-α after incision. The first peak is related to the acute inflammation, which appeared within 3 h after incision.29 The second peak is present around 72 h and is recognized as a response to wound remodeling.29,30 In our research, we did not test the level of cytokine at 3 h after incision. So we did not capture the first peak of the increase of cytokine. Previous studies showed that activated keratinocytes proliferate and express IL-1β and TNF-α after fracture and that excess amounts of inflammatory mediators in the skin cause sustained nociceptive sensitization.10 In the setting of skin incision, the neuropeptide substance P and CGRP released from peripheral nociceptive nerve ends can activate keratinocytes to release IL-1β, TNFα and other inflammatory cytokines and then contribute to the maintainance of peripheral sensitization.31
We found the peak of IL-1β (TNF-α) expression in keratinocytes appeared at three days after incision in C57BL/6J mice, which is in agreement with previous studies.29,30 But in diabetic mice, our data showed the peak time of IL-1β and TNF-α expression in keratinocytes was significantly delayed. Some studies reported that the healing impairment in the diabetic chronic wound is mainly related to a state of persistent hyper-inflammation characterized by decreased macrophage function.32–35 Hyperglycemia stimulate cytokine production and promote inflammation through activating MAP kinase or PKC pathways.36,37 Advanced glycation end products that accumulate in chronic hyperglycemia also promote inflammation.38,39 In our study, we also found that the expression of IL-1β (TNF-α) in keratinocytes maintained in a high level from three to seven days after incision in KK mice. The prolonged duration of pain hypersensitivity in KK mice may be attributed to the high level of IL-1β and TNF-α in keratinocytes.
In summary, our findings demonstrated that plantar incision may induce the slow and persistent proliferation of keratinocytes and expression of IL-1β and TNF-α in keratinocytes, which might be associated with the prolonged pain hypersensitivity in diabetic animals. Our study may provide a new insight into the mechanisms underlying diabetic or nondiabetic postoperative pain.
Author Contributions
RG and YW conceived the idea and acquired funding. RG, JH, DM, HL, and KL acquired and analyzed the data. RG drafted the paper. YW revised the article critically for intellectual content. All authors discussed the results on the manuscript.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Natural Science Foundation of China (81571065, 81771181), Natural Science Foundation of Beijing (7202053), Beijing Hospitals Authority Youth Program (QML20180105), and Scientific Research Common Program of Beijing Municipal Commission of Education (KM201910025018).
ORCID iD
References
- 1.Zahn PK, Brennan TJ. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain. Anesthesiology 1998; 88: 143–156. [DOI] [PubMed] [Google Scholar]
- 2.Sahbaie P, Shi X, Guo TZ, Qiao Y, Yeomans DC, Kingery WS, Clark JD. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 2009; 145: 341–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005; 31: 674–686; discussion 686. [DOI] [PubMed] [Google Scholar]
- 4.Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219–1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.O’Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997; 29: 63–78. [DOI] [PubMed] [Google Scholar]
- 6.Servold SA. Growth factor impact on wound healing. Clin Podiatr Med Surg 1991; 8: 937–953. [PubMed] [Google Scholar]
- 7.Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991; 45: 319–326. [DOI] [PubMed] [Google Scholar]
- 8.Angst MS, Clark JD, Carvalho B, Tingle M, Schmelz M, Yeomans DC. Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study. Pain 2008; 139: 15–27. [DOI] [PubMed] [Google Scholar]
- 9.Yan T, Zhang J, Tang D, Zhang X, Jiang X, Zhao L, Zhang Q, Zhang D, Huang Y. Hypoxia regulates mTORC1-mediated keratinocyte motility and migration via the AMPK pathway. PLoS One 2017; 12: e0169155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Li WW, Guo TZ, Li XQ, Kingery WS, Clark JD. Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain 2010; 151: 843–852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sabsovich I, Guo TZ, Wei T, Zhao R, Li X, Clark DJ, Geis C, Sommer C, Kingery WS. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 2008; 137: 507–519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sabsovich I, Wei T, Guo TZ, Zhao R, Shi X, Li X, Yeomans DC, Klyukinov M, Kingery WS, Clark JD. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 2008; 138: 47–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Li WW, Sabsovich I, Guo TZ, Zhao R, Kingery WS, Clark JD. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain 2009; 144: 303–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005; 167: 59–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, Golinko M, Rosenberg H, Tomic-Canic M. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 2007; 13: 30–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Karci A, Tasdogen A, Erkin Y, Aktaş G, Elar Z. The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiol Scand 2004; 48: 619–624. [DOI] [PubMed] [Google Scholar]
- 17.Pogatzki EM, Raja SN. A mouse model of incisional pain. Anesthesiology 2003; 99: 1023–1027. [DOI] [PubMed] [Google Scholar]
- 18.Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63. [DOI] [PubMed] [Google Scholar]
- 19.Sun BK, Siprashvili Z, Khavari PA. Advances in skin grafting and treatment of cutaneous wounds. Science 2014; 346: 941–945. [DOI] [PubMed] [Google Scholar]
- 20.Tanimoto M, Fan Q, Gohda T, Shike T, Makita Y, Tomino Y. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice. Metab Clin Exp 2004; 53: 1473–1479. [DOI] [PubMed] [Google Scholar]
- 21.Ribnicky DM, Poulev A, Watford M, Cefalu WT, Raskin I. Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 2006; 13: 550–557. [DOI] [PubMed] [Google Scholar]
- 22.Usui ML, Underwood RA, Mansbridge JN, Muffley LA, Carter WG, Olerud JE. Morphological evidence for the role of suprabasal keratinocytes in wound reepithelialization. Wound Repair Regen 2005; 13: 468–479. [DOI] [PubMed] [Google Scholar]
- 23.Pang Z, Sakamoto T, Tiwari V, Kim YS, Yang F, Dong X, Guler AD, Guan Y, Caterina MJ. Selective keratinocyte stimulation is sufficient to evoke nociception in mice. Pain 2015; 156: 656–665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Radtke C, Vogt PM, Devor M, Kocsis JD. Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain 2010; 148: 94–102. [DOI] [PubMed] [Google Scholar]
- 25.Cook SP, McCleskey EW. Cell damage excites nociceptors through release of cytosolic ATP. Pain 2002; 95: 41–47. [DOI] [PubMed] [Google Scholar]
- 26.Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, Petersen K, Eisenberg E, Wymer JP, Rice FL, Waxman SG. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain 2008; 139: 90–105. [DOI] [PubMed] [Google Scholar]
- 27.Dussor G, Koerber HR, Oaklander AL, Rice FL, Molliver DC. Nucleotide signaling and cutaneous mechanisms of pain transduction. Brain Res Rev 2009; 60: 24–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ren K, Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev 2009; 60: 57–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Grellner W, Georg T, Wilske J. Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 2000; 113: 251–264. [DOI] [PubMed] [Google Scholar]
- 30.Kondo T, Ohshima T. The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination. Int J Legal Med 1996; 108: 231–236. [DOI] [PubMed] [Google Scholar]
- 31.Qiao LN, Liu JL, Tan LH, Yang HL, Zhai X, Yang YS. Effect of electroacupuncture on thermal pain threshold and expression of calcitonin-gene related peptide, substance P and gamma-aminobutyric acid in the cervical dorsal root ganglion of rats with incisional neck pain. Acupunct Med 2017; 35: 276–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bjarnsholt T, Kirketerp-Møller K, Jensen P Ø, Madsen K G, Phipps R, Krogfelt K, Høiby N, Givskov M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2–10. [DOI] [PubMed] [Google Scholar]
- 33.Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98–107. [DOI] [PubMed] [Google Scholar]
- 34.Maruyama K, Asai J, Ii M, Thorne T, Losordo D W, D’Amore P A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178–1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736–1743. [DOI] [PubMed] [Google Scholar]
- 36.Wilmer WA, Dixon CL, Hebert C. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 2001; 60: 858–871. [DOI] [PubMed] [Google Scholar]
- 37.Devaraj S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-α and -β. Diabetes 2005; 54: 85–91. [DOI] [PubMed] [Google Scholar]
- 38.Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498: 99–111. [DOI] [PubMed] [Google Scholar]
- 39.Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002; 251: 87–101. [DOI] [PubMed] [Google Scholar]




